AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminac M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

NACC Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliminac M 1mg/500mg Tablet

Diabexa Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation assists in regulating blood glucose. Diabexa Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive treatment plan incorporating a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to counteract them. Regular meals and carrying a quick-acting glucose source (e.g., sugary snacks or juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (checking blood cell counts and liver function) may be recommended by your doctor.

Uses of Gliminac M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Gliminac M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliminac M 1mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Gliminac M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminac M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gliminac M 1mg/500mg tablets with a meal.

How Gliminac M 1mg/500mg Tablet works:

Gliminac M 1mg/500mg tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliminac M 1mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminac M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Gliminac M 1mg/500mg tablets due to the potential for infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Gliminac M 1mg/500mg tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliminac M 1mg/500mg tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminac M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiating therapy with a low dose of Gliminac M 1mg/500mg tablets is generally recommended; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Gliminac M 1mg/500mg Tablet :

Should you forget a Gliminac M 1mg/500mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Gliminac M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminac M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Gliminac M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Gliminac M 1mg/500mg Tablets and seek immediate medical attention.
Gliminac M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliminac M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliminac M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Gliminac M 1mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliminac M 1mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Gliminac M 1mg/500mg Tabl...
58
MRP 71
18% off